262 related articles for article (PubMed ID: 9092286)
1. Organ-sparing treatment of bladder cancer: an innovative approach.
Kaufman DS; Shipley WU
Am Fam Physician; 1997 Mar; 55(4):1257-62. PubMed ID: 9092286
[TBL] [Abstract][Full Text] [Related]
2. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
[TBL] [Abstract][Full Text] [Related]
3. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
4. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
[TBL] [Abstract][Full Text] [Related]
5. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL
J Urol; 1999 Aug; 162(2):445-50; discussion 450-1. PubMed ID: 10411054
[TBL] [Abstract][Full Text] [Related]
6. [Bladder cancer: realities and perspectives].
Chrétien Y; Oudard S; Durdux C
Bull Cancer; 2003 Jan; 90(1):61-7. PubMed ID: 12609806
[TBL] [Abstract][Full Text] [Related]
7. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
Pansadoro V; Emiliozzi P
Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
[TBL] [Abstract][Full Text] [Related]
9. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
Merseburger AS; Kuczyk MA
Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
[TBL] [Abstract][Full Text] [Related]
10. [Combined therapy for patients with invasive bladder cancer].
Startsev VIu; Karelin MI
Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
[TBL] [Abstract][Full Text] [Related]
11. Multimodality therapy for the treatment of muscle-invasive bladder cancer.
Thurman SA; DeWeese TL
Semin Urol Oncol; 2000 Nov; 18(4):313-22. PubMed ID: 11101096
[TBL] [Abstract][Full Text] [Related]
12. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
13. Organ-sparing strategies in the management of invasive bladder cancer.
Yafi FA; Cury FL; Kassouf W
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
[TBL] [Abstract][Full Text] [Related]
14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Herr HW
Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Witjes JA
Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
[No Abstract] [Full Text] [Related]
17. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
Fernando SA; Sandler HM
Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
[TBL] [Abstract][Full Text] [Related]
18. Current status of radiation therapy and combined-modality treatment for bladder cancer.
Rödel C
Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
20. Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer.
Kuczyk M; Machtens S; Bokemeyer C; Kollmannsberger C; Hartmann J; Kondoh M; Merseburger A; Jonas U
World J Urol; 2002 Aug; 20(3):183-9. PubMed ID: 12196902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]